Fluoropyrimidine adjuvant chemotherapy leads to long-term impact on coronary arteries, blood cell profile and iron in colorectal cancer survivors
Medicinski Glasnik · 2025
DOI: 10.17392/1936-22-02 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicinski Glasnik, 2025. Verfasst von Ivana Iveljic und 3 weiteren Autor:innen. Beteiligte Einrichtung: University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Fluorouracil, Capecitabine, Coronary Artery Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
<p><strong>Aim</strong> To assess whether colorectal carcinoma (CRC) survivors 5 years post-fluoropyrimidine (5-fluorouracil and capecitabine) chemotherapy (ChemT) have increased presence of subclinical coronary artery disease (CAD), lower iron and altered blood cell composition.</p> <p><strong>Methods </strong>This prospective, 2 year, single-center study used invasive coronary angiography to detect the presence of CAD among ChemT (N=45) and control group patients (age, gender-matched, cancer-naïve (N=45). Full blood count and iron levels were compared between two groups.</p> <p><strong>Results </strong>Coronary angiography in 90 patients (mean age 65±7 years; 60% male) identified significantly higher presence of CAD in CRC ChemT patient group compared to control: 80% vs. 55 % (p=0.013). CRC ChemT patients had lower red blood cell count (4.45± 0.56 vs. 4.68± 0.50 x10<sup>9</sup>/L; p=0.044), platelet count (214.18±50.99 vs. 251.00 ±156.40 x10<sup>9</sup>/L; p=0.002) and white blood cell count (5.50 ±1.62 vs. 7.67±1.72 x10<sup>9</sup>/L; p=0.000)<strong>.</strong> Mean corpuscular hemoglobin concentration was higher in CRC ChemT patients (342.11 g/L ±15.74 vs. 336.42 g/L ±10.29: p=0.046), and iron deficiency was more prevalent (ChemT20.40 µmol/L ±3.891vs. control 23.37 µmol/L ±4.10: p=0.001).</p> <p><strong>Conclusion </strong>Our study shows that among CRC survivors who underwent 5-FU and capecitabine therapy there is a significantly higher prevalence of CAD accompanied by long-term impairment in blood erythropoiesis.</p> <p><strong>Keywords</strong>: coronary artery disease, coronary angiography, erythropoiesis</p>
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina.
- William Harvey Research Institute, London, United Kingdom.
Zitieren
APA
Iveljic, I., Alidzanovic Nurkanovic, L., Krdzalic, A., & Aksentijevic, D. (2025). Fluoropyrimidine adjuvant chemotherapy leads to long-term impact on coronary arteries, blood cell profile and iron in colorectal cancer survivors. Medicinski Glasnik. https://doi.org/10.17392/1936-22-02
Vancouver
Iveljic I, Alidzanovic Nurkanovic L, Krdzalic A, Aksentijevic D. Fluoropyrimidine adjuvant chemotherapy leads to long-term impact on coronary arteries, blood cell profile and iron in colorectal cancer survivors. Medicinski Glasnik. 2025. doi:10.17392/1936-22-02
BibTeX
@article{Iveljic2025,
author = {Iveljic, Ivana and Alidzanovic Nurkanovic, Lejla and Krdzalic, Alisa and Aksentijevic, Dunja},
title = {Fluoropyrimidine adjuvant chemotherapy leads to long-term impact on coronary arteries, blood cell profile and iron in colorectal cancer survivors},
journal = {Medicinski Glasnik},
year = {2025},
doi = {10.17392/1936-22-02}
}
EUVIMED